The latest results show that one pharmacy group's contribution to revenue is more than 30% of the total. This is a rather high exposure when margins are tightening. PBS reforms are projected to soon take a sizeable cut out of many customers cash flow & profits. Seems a bit tight on wiggle room so I'm still cautious.
Comment only (no longer a holder). DYOR.
- Forums
- ASX - By Stock
- SIP
- looking good
looking good, page-2
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)